The World of Health & Medicine News

Number of steps taken matters more for better health in older women than the frequency, study suggests

Number of steps taken matters more for better health in older women than the frequency, study suggests

Clocking up at least 4,000 daily steps on just one or two days per week is linked to a lower risk of death and cardiovascular disease among older women, finds research published online in the British Journal of Sports Medicine.

Researchers found that achieving at least 4,000 steps per day on one or two days per week was associated with a significantly lower risk of death and lower risk of cardiovascular disease (CVD), compared with not reaching this level on any day.

A large body of evidence shows that lifelong physical activity is important for improving the health span, say the researchers. But it’s not entirely clear how much physical activity people should do as they age to reap appreciable health benefits, particularly in respect of step counts, which are yet to make it into physical activity guideline recommendations, they add.

To explore this further, they set out to look at the associations between daily step counts of between 4,000 and 7,000 and death from all causes and from CVD in older women.

They also wanted to find out if the total number of daily steps might drive any observed associations, rather than the frequency of achieving step count thresholds, with a view to informing future guidelines–in particular the US Physical Activity Guidelines, the next edition of which is planned for 2028.

The study followed 13,547 women (average age 71) from the U.S. Women’s Health Study who wore accelerometers (activity trackers) for seven consecutive days between 2011–2015 and were tracked for nearly 11 years. The women were free of CVD or cancer at the start of the study.

During the monitoring period of nearly 11 years up to the end of 2024, 1,765 women (13%) died and 781 (5%) developed CVD.

Clocking up at least 4,000 steps/day on one or two days of the week was associated with a 26% lower risk of death from all causes and a 27% lower risk of CVD death compared with not reaching this threshold on any day of the week.

For those achieving this step count on at least three days of the week, the lower risk of death from any cause increased to 40%, but remained at 27% for the risk of cardiovascular death.

But while higher daily step counts of 5,000 to 7,000 on three or more days of the week were associated with a further fall in the risk of death from any cause—32%—-they were associated with a leveling out in the risk of a CVD death—16%.

When the findings were adjusted to take account of average daily steps, previously observed associations weakened, suggesting that [average] steps is the key driver of the protective effect, suggest the researchers.

This is an observational study, and as such, no firm conclusions can be drawn about cause and effect. The researchers also acknowledge that physical activity was assessed only for one week, and therefore couldn’t account for variations in behavior over longer periods, nor did they have information on dietary patterns.

Nevertheless, they suggest, “The present study….suggests that frequency of meeting daily step thresholds is not critical (even one to two days/week of ≥4,000 steps/day was related to lower mortality and CVD), and that step volume is more important than the frequency of meeting daily step thresholds in the older population.”

And they go on to explain, “An important translational implication of these findings is that since step volume is the important driver of the inverse associations, there is no ‘better’ or ‘best’ pattern to take steps; individuals can undertake [physical activity] in any preferred pattern (e.g., ‘slow and steady’ vs. ‘bunched patterns’) for lower mortality and CVD risk, at least among older women.”

spot_img

Explore more

spot_img

GSK enters lung cancer drug market with early FDA nod for...

GSK enters lung cancer drug market with early FDA nod for Jideytro GSK (GSK.L), opens new tab said on Wednesday the U.S. FDA approved its drug ​to...

Working from home could be harming your health, warns Chris Whitty

Working from home could be harming your health, warns Chris Whitty England’s chief medical officer has issued a warning about the health dangers of prolonged sitting, coinciding...

Popular sugar substitutes linked to faster brain aging

Popular sugar substitutes linked to faster brain aging Several popular sugar substitutes may not be as harmless as they seem. Adults who consumed the most...

 The Best Time to Eat Peaches for Energy, According to a...

The Best Time to Eat Peaches for Energy, According to a Dietitian Peaches are a juicy, naturally sweet, nutritious, and refreshing fruit. While there’s no...

FDA approves at-home starter dose of Eisai-Biogen Alzheimer’s drug

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug The U.S. FDA on Monday approved an at-home starting dose of Eisai's (4523.T), opens new tab and Biogen's (BIIB.O),...

The One Healthy Food That Might be Spiking Your ‘Bad’ Cholesterol

The One Healthy Food That Might be Spiking Your 'Bad' Cholesterol Coconut oil has enjoyed a long run as a wellness favorite. It's been blended...

US FDA approves Vertex’s gene therapy for sickle cell disease in...

US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two The U.S. Food and Drug Administration approved expanded use...

FDA clears Orca’s blood cancer therapy to reduce stem cell transplant...

FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications The U.S. Food and Drug Administration said on ​Tuesday it has approved Orca...